| Systematic (IUPAC) name | |
|---|---|
|
N-(1,1-dimethylethyl)-3-oxo- (5α,17β)-4-azaandrost-1-ene-17-carboxamide |
|
| Clinical data | |
| Trade names | Proscar |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a698016 |
| Pregnancy cat. | X (will cause birth defects in an unborn baby) |
| Legal status | POM (UK) ?-only (US) |
| Routes | Oral |
| Pharmacokinetic data | |
| Bioavailability | 63% |
| Metabolism | Hepatic |
| Half-life |
Elderly: 8 hours Adults: 6 hours |
| Excretion | Feces (57%) and urine (39%) as metabolites |
| Identifiers | |
| CAS number | 98319-26-7 Y |
| ATC code | G04CB01 D11AX10 |
| PubChem | CID 57363 |
| DrugBank | APRD00632 |
| ChemSpider | 51714 Y |
| UNII | 57GNO57U7G Y |
| KEGG | D00321 Y |
| ChEBI | CHEBI:5062 Y |
| ChEMBL | CHEMBL710 Y |
| Chemical data | |
| Formula | C23H36N2O2 |
| Mol. mass | 372.549 g/mol |
| SMILES | eMolecules & PubChem |
